7/26/23

Doubling Down on Failed Drug Price Controls, More Drug Shortages, and Fewer Treatments

 Read More
7/23/23 - The New York Times

Drugmakers Are ‘Throwing the Kitchen Sink’ to Halt Medicare Price Negotiations

 Read More
7/21/23

CAHC Comments on Pallone-Murray Public Option RFI

 Read More
placeholder image
6/1/23

An Inflation Reduction Act Drug Provision Is Backfiring

 Read More
placeholder image
5/24/23

MVP Act is the Most Valuable Piece of Legislation in Combatting High Healthcare Costs

 Read More
placeholder image
5/10/23

INNOVATION & ACCESS CAN’T HAPPEN WITH INFLATION REDUCTION ACT’S RESTRICTIVE POLICIES

 Read More
placeholder image
4/27/23

OUTCOMES-BASED ARRANGEMENTS ARE KEY TO LOWERING HEALTHCARE COSTS

 Read More
placeholder image
4/22/23

New Rx Legislation: Government-Run Drug Benefits Wrong For Patients

 Read More
placeholder image
4/14/23

CMS MUST ADDRESS THE FAILINGS OF THE INFLATION REDUCTION ACT

 Read More
placeholder image
3/28/23

PRICE CONTROLS KEEP THE CANCER MOONSHOT ON THE LAUNCH PAD

 Read More
placeholder image
3/16/23

CAHC Statement: Congress Should Enact Bi-Partisan Solutions, Not Government Price Controls

 Read More
placeholder image
3/9/23

A CANCER MOONSHOT DOESN’T LEAVE THE LAUNCH PAD WITH PRICE CONTROLS

 Read More

Search CAHC